Robert A. Waterman Sells 33,786 Shares of HCA Healthcare Inc (NYSE:HCA) Stock

HCA Healthcare Inc (NYSE:HCA) SVP Robert A. Waterman sold 33,786 shares of the business’s stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $134.98, for a total transaction of $4,560,434.28. Following the completion of the transaction, the senior vice president now directly owns 279,551 shares of the company’s stock, valued at approximately $37,733,793.98. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Shares of HCA stock traded down $2.46 during trading hours on Friday, reaching $119.78. 1,110,797 shares of the company’s stock were exchanged, compared to its average volume of 2,028,713. The stock’s 50 day moving average is $133.26 and its 200-day moving average is $130.99. The company has a market cap of $41.68 billion, a price-to-earnings ratio of 12.26, a P/E/G ratio of 1.05 and a beta of 0.85. HCA Healthcare Inc has a fifty-two week low of $110.31 and a fifty-two week high of $147.42.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, July 30th. The company reported $2.21 earnings per share for the quarter, missing analysts’ consensus estimates of $2.49 by ($0.28). The company had revenue of $12.60 billion for the quarter, compared to analysts’ expectations of $12.61 billion. HCA Healthcare had a net margin of 7.46% and a negative return on equity of 135.90%. HCA Healthcare’s quarterly revenue was up 9.3% compared to the same quarter last year. During the same period last year, the firm earned $2.29 earnings per share. On average, equities research analysts forecast that HCA Healthcare Inc will post 10.36 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Tuesday, September 3rd will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.34%. The ex-dividend date of this dividend is Friday, August 30th. HCA Healthcare’s dividend payout ratio (DPR) is presently 16.38%.

Institutional investors and hedge funds have recently made changes to their positions in the company. Doyle Wealth Management purchased a new stake in shares of HCA Healthcare during the second quarter valued at $34,000. Westside Investment Management Inc. purchased a new stake in HCA Healthcare in the second quarter valued at $34,000. NEXT Financial Group Inc purchased a new stake in HCA Healthcare in the second quarter valued at $43,000. Financial Gravity Wealth Inc. purchased a new stake in HCA Healthcare in the first quarter valued at $47,000. Finally, Valeo Financial Advisors LLC purchased a new stake in HCA Healthcare in the first quarter valued at $66,000. 70.32% of the stock is currently owned by hedge funds and other institutional investors.

A number of brokerages recently commented on HCA. Stephens set a $150.00 price objective on shares of HCA Healthcare and gave the stock a “buy” rating in a research note on Wednesday, August 7th. Goldman Sachs Group raised shares of HCA Healthcare from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $147.00 to $160.00 in a research note on Wednesday, July 10th. UBS Group boosted their price objective on shares of HCA Healthcare from $172.00 to $181.00 and gave the stock a “buy” rating in a research note on Monday, June 24th. Mizuho set a $153.00 price objective on shares of HCA Healthcare and gave the stock a “buy” rating in a research note on Wednesday, July 31st. Finally, Zacks Investment Research downgraded shares of HCA Healthcare from a “buy” rating to a “hold” rating and set a $130.00 price objective for the company. in a research note on Monday, May 27th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and seventeen have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $153.35.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

See Also: Does a trade war provide a risk to the global economy?

Insider Buying and Selling by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.